Precision Biologics to present data on new antibody-drug conjugate PB-223 ADC at AACR, Chicago, IL, April 25 – 30, 2025

Precision Biologics, Inc. will present new data on a newly developed Antibody-Drug Conjugate PB-223 ADC at the American Association for Cancer Research (AACR) Annual Meeting, April 25 – 30, 2025, McCormick Place Convention Center, Chicago, IL